Induction Regimens in High-Risk Neuroblastoma: Systematic Review of Response Rates and Toxicities
Cancer Med. 2025 Nov;14(22):e71312. doi: 10.1002/cam4.71312. ABSTRACT BACKGROUND: Numerous induction therapies have been evaluated for high-risk neuroblastoma (HRNBL). It is not known how these regimens’ …